trending Market Intelligence /marketintelligence/en/news-insights/trending/A67XHA_2px7fckvTiXLrmQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Hologic's tests to detect vaginal infections win US FDA nod


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Hologic's tests to detect vaginal infections win US FDA nod

The U.S. Food and Drug Administration approved Hologic Inc. Aptima BV and Aptima CV/TV tests to detect infections of the vagina.

Vaginitis generally refers to vaginal disorders caused by infection, inflammation or changes in the normal vaginal flora.

The tests can be used to detect vaginitis caused by bacterial vaginosis, vulvovaginal candidiasis — commonly known as a vaginal yeast infection — and trichomonas vaginalis infections. About 90% of vaginitis is caused by these types of infections in women.

Bacterial vaginosis is a type of vaginal inflammation caused by the overgrowth of bacteria naturally found in the vagina, which upsets the natural balance, while trichomoniasis a sexually transmitted disease caused by the single-celled protozoan parasite.

"The improved sensitivity and specificity of Hologic's molecular assays over traditional methods in determining the underlying cause of vaginitis not only means identifying the right infection, but enabling the right treatment and, in turn, reducing the potential for recurrent or persistent infections," said Edward Evantash, medical director and vice president of medical affairs at Hologic.

Hologic's Aptima multitest swab specimen kit help healthcare providers to test up to seven disease states and infections, including bacterial vaginosis, Candida species, Candida glabrata, trichomoniasis, chlamydia, gonorrhea and Mycoplasma genitalium.